BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36727873)

  • 1. 68 Ga-PSMA-Avid Intranasal Solitary Fibrous Tumor.
    Riaz S; Priftakis D; Afaq A; Kayani I; Bomanji J
    Clin Nucl Med; 2023 Apr; 48(4):e184-e185. PubMed ID: 36727873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solitary Fibrous Tumor of the Prostate Shown on FAPI PET/CT.
    Yang T; Zhu R; Guo Z; Niu X; Tao W
    Clin Nucl Med; 2023 Jun; 48(6):530-531. PubMed ID: 37133513
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wang R; Liu Q; Sui H; Zhang M; Zhu Z; Cui R
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):2055-2056. PubMed ID: 33469685
    [No Abstract]   [Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Case of Metastatic Solitary Fibrous Tumor (Hemangiopericytoma) of the Dura on 18F-FDG PET/CT.
    Grünig H; Skawran S; Stolzmann P; Messerli M; Huellner MW
    Clin Nucl Med; 2021 Sep; 46(9):768-769. PubMed ID: 34288634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral renal metastasis from intracranial solitary fibrous tumor/hemangiopericytoma revealed on
    Xiao L; Li L
    Hell J Nucl Med; 2021; 24(3):272-273. PubMed ID: 34901969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 68 Ga-DOTATOC PET/CT Imaging of a Muscular Solitary Fibrous Tumor.
    Richard C; Cros J; Seban RD; Champion L; Hescot S
    Clin Nucl Med; 2023 May; 48(5):e228-e229. PubMed ID: 36854307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
    Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
    Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 68 Ga-FAPI PET/CT Detected Non-PSMA/FDG-Avid Primary Tumor in De Novo Metastatic Prostate Cancer.
    Pang Y; Meng T; Xu W; Shang Q; Chen H
    Clin Nucl Med; 2022 Dec; 47(12):1108-1111. PubMed ID: 35961368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominopelvic Hemangiopericytoma Mimicking Neuroendocrine Tumor on 68 Ga-DOTANOC PET/CT.
    Prakash S; Shamim SA; Rastogi S
    Clin Nucl Med; 2023 Apr; 48(4):e193-e194. PubMed ID: 36727901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
    Sasikumar A; Joy A; Pillai MR; Nanabala R; Anees K M; Jayaprakash PG; Madhavan J; Nair S
    Clin Nucl Med; 2017 Jan; 42(1):e41-e48. PubMed ID: 27846000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18)F-FDG PET/CT imaging of malignant hepatic solitary fibrous tumor.
    Song L; Zhang W; Zhang Y
    Clin Nucl Med; 2014 Jul; 39(7):662-4. PubMed ID: 24686215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 68 Ga-PSMA-Avid Liver Metastases From Colon Cancer, Not Visualized on FDG PET Scan.
    Doroudinia A; Chekuri S
    Clin Nucl Med; 2023 Nov; 48(11):e547-e548. PubMed ID: 37756469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined [68 Ga]Ga-PSMA-11 and low-dose 2-[18F]FDG PET/CT using a long-axial field of view scanner for patients referred for [177Lu]-PSMA-radioligand therapy.
    Alberts I; Schepers R; Zeimpekis K; Sari H; Rominger A; Afshar-Oromieh A
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):951-956. PubMed ID: 36136102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Triple-Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol.
    Pouliot F; Beauregard JM; Saad F; Trudel D; Richard PO; Turcotte É; Rousseau É; Probst S; Kassouf W; Anidjar M; Camirand Lemyre F; Bouvet GF; Neveu B; Tétu A; Guérin B
    BJU Int; 2022 Sep; 130(3):314-322. PubMed ID: 34674367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of diagnostic efficacy of
    Zhang B; He Q; Long Y; Zhang Y; Wang X; Chen Z; Liu J; Zhang X
    Front Endocrinol (Lausanne); 2022; 13():962800. PubMed ID: 36213295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron Emission Tomography/Computed Tomography in Thyroid Cancer.
    Bal C; Chakraborty D; Khan D
    PET Clin; 2022 Apr; 17(2):265-283. PubMed ID: 35256297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary Fibrous Tumor of the Bone Detected by FDG PET/CT.
    Li J; Kuang A; Shen G
    Clin Nucl Med; 2022 Oct; 47(10):e660-e662. PubMed ID: 35619204
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    El-Maouche D; Sadowski SM; Papadakis GZ; Guthrie L; Cottle-Delisle C; Merkel R; Millo C; Chen CC; Kebebew E; Collins MT
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3575-3581. PubMed ID: 27533306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
    Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T
    Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.